Issued Patents All Time
Showing 1–24 of 24 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12358960 | Selective targeting of ubiquitin- and ubiquitin-like E1-activating enzymes by structurally-stabilized peptides | Loren D. Walensky, Ann Morgan Cathcart | 2025-07-15 |
| 12344643 | Compositions and methods for inhibition of FOXP3 | James LaBelle, Rachel Eclov, Loren D. Walensky | 2025-07-01 |
| 12153051 | Reagents for quantitative mass spectrometry | Craig Braun, Wilhelm Haas, Steven P. Gygi, Loren D. Walensky, Martin Helmut Wuhr +1 more | 2024-11-26 |
| 11982674 | Reagents for quantitative mass spectrometry | Craig Braun, Wilhelm Haas, Steven P. Gygi, Loren D. Walensky, Martin Helmut Wuhr +1 more | 2024-05-14 |
| 11834520 | Selective targeting of apoptosis proteins by structurally-stabilized and/or cysteine-reactive NOXA peptides | Loren D. Walensky, Rachel Guerra, Edward Harvey | 2023-12-05 |
| 11466064 | Bcl-w polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing loss | Rosalind Segal, Loren D. Walensky, Lisa V. Goodrich, Sarah Elizabeth Raissi, Maria F. Murphy | 2022-10-11 |
| 11220532 | Targeting deregulated Wnt signaling in cancer using stabilized alpha-helices of BCL-9 | Loren D. Walensky, Ruben Carrasco | 2022-01-11 |
| 11169155 | Reagents for quantitative mass spectrometry | Craig Braun, Wilhelm Haas, Steven P. Gygi, Loren D. Walensky, Martin Helmut Wuhr +1 more | 2021-11-09 |
| 11142554 | Selective Mcl-1 binding peptides | Raheleh Rezaei-Araghi, Amy Keating, Loren D. Walensky | 2021-10-12 |
| 11105810 | Reagents for quantitative mass spectrometry | Craig Braun, Wilhelm Haas, Steven P. Gygi, Loren D. Walensky, Martin Helmut Wuhr +1 more | 2021-08-31 |
| 11078246 | Peptides binding to Bfl-1 | Loren D. Walensky | 2021-08-03 |
| 10716828 | Methods of modulating cellular homeostatic pathways and cellular survival | Nika N. Danial, Loren D. Walensky, Stanley J. Korsmeyer | 2020-07-21 |
| 10703785 | Targeting deregulated Wnt signaling in cancer using stabilized alpha-helices of BCL-9 | Loren D. Walensky, Ruben Carrasco | 2020-07-07 |
| 10487129 | Stabilized insulinotropic peptides and methods of use | Loren D. Walensky | 2019-11-26 |
| 10464975 | Stabilized anti-microbial peptides | Loren D. Walensky, Rida Mourtada | 2019-11-05 |
| 10308926 | Stablized EZH2 peptides | Loren D. Walensky, Woojin Kim, Stuart H. Orkin | 2019-06-04 |
| 10273290 | Hydrocarbon double-stapled stabilized HIV-1 GP41 heptad repeat domain peptides | Loren D. Walensky | 2019-04-30 |
| 10259848 | Compositions and methods comprising hydrocarbon-stapled polypeptides | Loren D. Walensky | 2019-04-16 |
| 10077290 | Stabilized antiviral fusion helices | Loren D. Walensky | 2018-09-18 |
| 9822165 | Hydrocarbon stapled stabilized alpha-helices of the HIV-1 GP41 membrane proximal external region | Loren D. Walensky | 2017-11-21 |
| 9695224 | Stabilized insulinotropic peptides and methods of use | Loren D. Walensky | 2017-07-04 |
| 9296805 | Stabilized insulinotropic peptides and methods of use | Loren D. Walensky | 2016-03-29 |
| 9290545 | Compositions and methods for the treatment of viral infections | Loren D. Walensky | 2016-03-22 |
| 8921323 | Methods and compositions for modulating BCL-2 family polypeptides | Loren D. Walensky, Nico Tjandra, Evripidis Gavathiotis, Motoshi Suzuki | 2014-12-30 |